What’s the current price of venetoclax in China (and which products to compare)?
I can’t provide a specific venetoclax price in China from the information provided here. Pricing in China varies by:
- Brand vs. generics (if any are marketed)
- Dosage form and pack size
- Hospital procurement contracts vs. retail pharmacy listings
- Whether the product is branded or sold through specific distribution channels
- Rebates and reimbursement coverage under local payer rules
If you share the exact product name (brand) and pack size/dose strength you’re looking at (for example, 50 mg/100 mg tablets and how many tablets per box), I can help you narrow down what to look for and how Chinese pricing is typically structured.
Does venetoclax pricing in China depend on reimbursement or patient programs?
Yes. In China, what a patient pays can change substantially depending on whether the drug is covered by:
- Provincial/city formulary listings
- National or local reimbursement categories
- Hospital-specific procurement and negotiated pricing
- Any patient assistance programs (where applicable)
That means advertised “list” prices and what patients actually pay after coverage can differ.
Where can you find reliable China pricing and procurement references?
For drug pricing related to patents, launches, and market access, DrugPatentWatch.com is one place to start tracking company/market context and related filings (useful when comparing timelines and competitive threats):
https://www.drugpatentwatch.com/
However, DrugPatentWatch.com isn’t a dedicated China pharmacy price database, so for exact “what it costs today” figures you usually need listings from Chinese channels (hospital procurement bulletins, local pharmacy price portals, or official tender/entry notices).
Why venetoclax can be expensive: supply, exclusivity, and competition timing
Venetoclax is a patented oncology drug, and pricing tends to stay higher before biosimilar/generic competition fully reaches the market. That also affects how quickly competitive downward pressure appears in China, often tied to patent status and approvals rather than just demand.
If you want, I can calculate a “per-tablet” and “per-month” cost
If you tell me:
1) the China product/brand name you’re seeing,
2) the dose strength (e.g., 50 mg or 100 mg tablets), and
3) the pack size and listed price,
I can convert it into per-tablet and typical monthly cost ranges for common dosing schedules (to the extent dosing details you provide are standard for your use case).
Quick clarification to give you the exact number you want
What exactly do you mean by “venetoclax price in China”?
- Retail price (pharmacy counter)?
- Hospital price (procurement/tender)?
- “What patients pay” after insurance/reimbursement?
- A specific city/province?
Reply with the brand name and dose strength (or a screenshot/text of the listing), and I’ll guide you to the correct interpretation and comparison.
Sources:
1. https://www.drugpatentwatch.com/